Clinical Development

The biosimulation specialist will harness TrialAssure’s Anonymize software to help anonymize patient clinical data for its future research studies.

The biosimulation specialist will harness TrialAssure’s Anonymize software to help anonymize patient clinical data for its future research studies.

With COVID-19 adding challenges to the already complex field, the April 6 Clinical Development Innovations webinar will share thoughtful solutions.

With COVID-19 adding challenges to the already complex field, the April 6 Clinical Development Innovations webinar will share thoughtful solutions.

Saamaâs range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development.

The two major pharmaceutical firms have agreed to jointly develop and commercialize treatment combinations of lenacapavir and islatravir in HIV patients.

The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90.

The development technology firm plans to use the funds, sourced from a wide range of investors, to expand its dev-ops platform and expand its global […]

The DT Clinical Trial Digital Tracker Survey indicates many trial professionals often are hesitant to dive fully into digital technology integration.

The companyâs technology facilitates remote patient monitoring and integrates with a wide range of wearable sensors for checking patient vital signs.

The CRO will receive funding to fuel a five-year Research Project Award, with the goal to design and conduct research of potential PTSD treatment options.

The 2020 Pfizer/BioNTech COVID-19 vaccine trial recruited more than 44,000 participants and reached submission for emergency authorization in 248 days: showing unprecedented speed and agility […]

According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer.

A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions.

The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants.

The partnership reportedly will center on optimizing integration for EHR data and remote-source data review to help accelerate clinical research results.

A leader from the risk-based quality management solutions provider will discuss the growing interest in the technology, during this yearâs SCOPE event.

An executive from the clinical trial technology provider will share how direct data capture can save time, avoid errors and improve the patient experience.

A leader from the global research services company shares how in-home services maximize patient convenience and COVID-19’s impact on clinical studies.

The annual event, moved to the virtual realm thanks to COVID-19, offers content on remote monitoring, drug development technology and other key topics.

A senior clinical research associate from the CRO discusses how the pandemic has touched her workday, and how she is dealing with the myriad challenges.

The technology is designed to streamline and simplify integration, data collection and analysis, and digital biomarker discovery with wearable sensors.

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and […]

A leader from the clinical data solutions firm explains how the challenges created by the pandemic have helped fuel creativity and innovation in studies.

A study by two trial technology firms reportedly indicates that decentralized trials are outperforming on-site in recruitment, retention and other aspects.

A new trial for the AstraZeneca/Oxford COVID-19 vaccine will investigate the efficacy of the vaccine in children aged six and over.

The American Heart Associationâs Heart of Communicating Science modules are designed to help experts break complex talk into easy-to-understand language.

Smart Meterâs iBloodPressure monitor enables automatic transmittal of results without docking stations, WiFi, syncing, apps or smartphones.

According to a company leader, electronic clinical outcome assessment solutions should take ease of use for patients, sponsors and others into account.

The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm’s tech and patient-centric approach.

Thanks to collaborations with Cerner, amassing of proprietary data and other achievements, the trial solutions firm has hit a significant access milestone.

The two companies are integrating their technologies in a move designed to help hasten trial launches, and get promising new treatments to market faster.

While the technology has been found mostly in dermatological applications, its use in studies is expanding, according to Illingworth Research Group.

Bioclinicaâs Image Redact AI tool enables trials to edit sensitive information from videos, photos and PDFs to ensure compliance and safeguard patient data

The companyâs medical imaging technology and other eClinical solutions reportedly played a part in half of the treatments to receive the FDA designation.

With fewer than 3% of analyzed genomes currently coming from Africans, the companies are looking to increase access to and understanding of patient data.

Conducted by SubjectWell, the survey of patients with Type 2 diabetes reveals how ethnicity and other factors play a part in trial participation tendencies.

Two leaders from the clinical technology solutions company discuss how digital tools like eCOAs have been invaluable in facing pandemic-related challenges.

The trials, funded by the American Heart Association, will harness the companyâs Verisense wearable sensor platform to examine brain-heart health links.

The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciencesâ VE202 inflammatory bowel disease treatment candidate.

A leader from Oracle Health Sciences examines the dynamic, challenging year and highlights creativity and ingenuity displayed by research professionals.

A representative from the global CRO outlines how forces like COVID-19, decentralized studies, globalization and others are driving change in the industry.

An executive with the clinical research tech firm explains that while such studies can be rife with problems, the right approach can yield results.

Conducted via a partnership between Parexel and CISCRP, the study reveals insights about the needs and concerns of pediatric patients and their families.

A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug […]

The Medical Data Platform, an RPM solution from VivaLINK, handles clinical trials, cardiac monitoring, remote and in-patient monitoring and other tasks.

A leader from the clinical trial solutions firm talks about the drive toward conducting trials without sites, and why that idea might lead to problems.

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

The head of the CROâs Global Center of Excellence for Decentralized Clinical Trial Strategy outlines key developments in 2020, and keys to success in 2021.

Look for advances in decentralized trials, data collection, remote monitoring and other areas, says a leader from the research tech solutions firm.

The newly formed group seeks to bring together research professionals to accelerate adoption and introduce industry standards in virtual and hybrid trials

The two firms will work together to broaden the technology, tools, and resources available to hospitals and practices in less-accessible communities.

The research (conducted by trial tech provider Litmus Health) shows an indepth picture of wearable device use, top devices, data capture and other factors.

The clinical trial tech firm has enhanced its electronic patient-reported outcome module, and landed an investment to help promote various technologies.

Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for womenâs cancers.

Through organizations like the Association of Clinical Research Organizations, clinical research professionals are helping decentralized research evolve.

An expert from the clinical research technology specialist discusses how trial teams can use real-world evidence to improve study inclusivity.

OSP’s free Digital Advances in Clinical Trial webinar (on December 9) will feature experts discussing recent advancements in the rapidly evolving field.

Taking place December 9, the Digital Advances in Clinical Trials webinar covers notable advances in clinical trial technology, and the future of the field.

The global biopharma is using Reify Healthâs StudyTeam software to streamline and automate clinical trial functions, including recruiting and enrollment.

A recent survey conducted by Oracle reveals trial professionalsâ thoughts, feelings and behavior around decentralized research in the face of the pandemic.

The company has received a $500,000 grant from the COVID-19 Therapeutics Accelerator to develop manufacturing processes for the antiviral drug remdesivir.

The decentralized trial tech firmâs Verisense inertial measurement unit sensor has received the seal of approval from the Conformità EuropÃenne.

The two companies will collaborate on a Phase III clinical trial investigating a potential treatment for patients hospitalized with COVID-19.

Intelligent Tissue Group has launched its Intelligent Clinical trials facility to help assess the effectiveness and safety of potential new treatments.

A leader from the CRO discusses how the COVID-19 pandemic has accelerated decentralized adoption, and how such trials lead to benefits for participants.

According to one New Yorker, encountering the AI-assisted TrialJectory technology helped cut through the uncertainty to provide information and solutions.

The precision medicine firm is joining with the oncology network in an effort to help improve treatment options and outcomes for cancer patients worldwide.

An expert from the global pharmaceutical firm shares how working with other organizations and putting patients at the center can benefit clinical research.

A leader from the trial patient services specialist discusses the importance of keeping the participantâs vital role top of mind in research studies.

During a free editorial webinar on December 9, a panel of clinical trial experts will offer a range of insights into the future of research […]

A leader from the global CRO talks about how use of RWE in clinical trials can benefit research sites and sponsors, and satisfy regulatory requirements.

With its new TeleCOA technology, the company offers trials a way to incorporate electronic clinical outcome assessments with telemedicine visits.

A leader from the clinical research technology firm shares perspective on the benefits Bayesian trial design, an approach dating back to the 1700s.

The clear evidence of increased risk of COVID-19 infection amongst ethnic minority groups, people from Black and Asian backgrounds, is of urgent public health importance, […]

Preliminary results from a recent clinical trial indicate the drug touted by US leaders as a possible treatment offers no significant benefit to patients.

According to a survey by trial solutions company Greenphire, patient recruitment and enrollment levels have bounced back since the pandemic struck.

With the Open Wearables initiative, Shimmer Research is looking to bring research professionals together on solutions for the common good of the industry.

The company has announced its Ignite platform has been integrated with the Clinical Research IO clinical trial management software platform.

A leader from life-science solutions firm RBW Consulting says remote monitoring can help clinical trials move forward, despite formidable challenges.

With an infusion of capital from investors 1315 Capital, ProSciento is setting its sights on expansion of its specialized clinical research services.

The companies are partnering to help expand much-needed access to decentralized clinical trials for central nervous system patients and caregivers.

The latest analytical report from Life Science Strategy Group reveals position and perception of the leading players and performers in the eClinical arena.

Mission Bio has launched a tool it claims will help save the industry billions of dollars in drug development costs and bring life-saving treatments to […]

During the CRAACO conference, a leader from the study solutions firm will discuss how researchers can learn and benefit from the other industry.

In order to effectively handle collection and analysis of huge volumes of vital data, a leader from IQVIA advises bringing on people up to the […]

A leader from the cancer patient matching and analysis solutions firm discusses how and other forces are pushing innovation in the oncology research space.

This year the conference brings its content, focused on the intersection of clinical research and patient care, from the real world to the virtual one.

A new movement is working to bring leaders together from all corners of clinical research for to work toward the continued success of the industry.

The two companies are working together to develop AT-527, an orally administered, direct-acting antiviral therapy for patients diagnosed with COVID-19.

Built with Gilead, the RWD-based technology is designed to offer pharma firms and research partners a more effective way to verify product safety.

The clinical research solutions firm is joining forces with pharma giant Eli Lilly to manage mobile research of the monoclonal antibody LY-CoV555.

The collaboration will target signs of early deterioration in patients, and predict infection severity to let caregivers know when to escalate care.

The US agency has launched a large clinical trial to examine the viability of using immune modulators to treat patients hospitalized with COVID-19.

A leader from a New Zealand-based CRO talks about the countryâs handling of the pandemic, and how their low rates are making sponsors take notice.

The CRO and life-sciences tech firm collaborated on a solution capable of meeting challenges tied to starting and conducting global clinical trials.

The agencyâs Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality.

The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization.

The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial.

Study solutions provider Hū blends behavioral science, decision economics and technology to better integrate the patient voice into clinical research.

eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products.

A veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.

Neurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimerâs disease, with the help of a $2.7m NIH grant.

Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials.

The companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month.

The health solutions firm is looking to remote patient monitoring to overcome significant clinical trial obstacles created by the ongoing pandemic.

The companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.

TeleConsent empowers trial teams to obtain informed consent and re-consent from patients participating in clinical studies, within a fully remote system.

The Clinventory inventory management system is designed to help study sponsors streamline management of their clinical trial inventory and supplies.

Results from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent.

The AI platform combines machine-learning models and advanced semantic technologies to help life-science users gain insights from their data.

The technology combines predictive analytics and commercial services to help pharma firms and partners maximize drug discovery and development efforts.

The research platform provider will work with the healthcare system to provide GI patients broader diagnostics and treatment.

The CRO will work with the Leukemia and Lymphoma Society on a global master clinical trial to explore treatments for pediatric acute leukemia.

The companies will work together on solutions designed to enable sponsors to improve imaging, respiratory and cardiac safety data on decentralized trials.

The company has released a report revealing how clinical trial professionals are handling start-up, before and after COVID-19 first impacted the industry.

Led by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemicâs effects.

An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments.

A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going.

The companyâs AI-powered Clinsite investigator site intelligence platform now offers country selection, designed to help streamline trial efficiency.

The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam.

A partnership between two trial tech providers aims to create a more powerful, efficient and effective study solution for sites, sponsors and CROs.

American Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.

A leader from the clinical research solutions provider discusses the ways pandemic has shaken the trial industry, and how to tackle the obstacles.

The company is joining with ICER to help promote use of robust, repeatable indirect comparisons in health tech assessments.

Experts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.

A leader from IBM Watson Health talks about how its advanced EDC solution is geared toward helping studies save precious time and conserve costs.

Researchers at ACM Global Laboratories are focused on aiding clinical trials working on treatments for the deadly virus behind the current pandemic.

A leader at the companyâs Acorn AI Labs talks about ways the pandemic has impacted the industry, and how researchers must adapt to a new […]

Use of electronic patient-recorded outcome data can lead to more accurate trial data, and a better patient experience, according to the CRO.

Partnering with Cogstate, the company is seeking to enhance its eCOA solution, with the goal of ultimately boosting the speed and effectiveness of trials.

A representative from the pharma services firm discusses how increasing diversity of clinical trial populations can improve research effectiveness.

Elucid Digital Healthâs Pill Connect is designed to enable CROs and pharma companies to monitor patient adherence during a clinical trial.

The CRO has been tapped by the Frederick National Laboratory for Cancer Research to provide clinical services for an ongoing COVID-19 study

The company has expanded the footprint of the location to accommodate an anticipated increase in the need for COVID-19 vaccine and storage needs.

An industry expert from the global CDMO offers advice on how to plan for a successful clinical trial supply chain, and avoid mistakes along the […]

With the acquisition of HVH Precision Analytics, the company has added new advanced analytics capabilities to its roster of life-sciences services.

A leader from the CRO shares perspectives on the challenges and rewards associated with the category, and approaches in getting generics to market.

The two firms will collaborate on an effort to integrate real-world data into clinical trial technology on a broad range of projects.

A leader with the health data specialists looks at how COVID-19 has impacted the clinical research industry, and what the future of the field might […]

The clinical development and consulting firm has signed a three-year service agreement to support the pharma firm with development service solutions.

The companies will work together on putting in place technology to facilitate remote monitoring and document review for COVID-19 studies and other research.

The company has opened the doors of a new manufacturing facility designed to create and manufacture a range of wearable drug delivery devices.

A leader from the healthcare solutions firm shares perspective on how application of advanced technologies has driven the evolution of the entire industry.

Using apps and AI technology, Belong.Life brings together cancer patients and current clinical research projects, to further development of therapies.

The UK-based collaboration will include expertise across more than 40 types of cancer, with access to patients from more than 170 referring oncologists.

HealthTree is a crowdsourcing platform that enables patients diagnosed with the rare blood cancer to find clinical trials and contribute to a cure.

Enterome completes Series E financing round, with Takeda returning to provide funds to the biotech.

A representative from the clinical trial financial solutions firm tells Outsourcing-Pharma that tech can clear budget-related trial tangles.

The agency has given the thumbs up for Rukobia, a treatment designed for HIV patients facing poor results with current antiretroviral therapies.

The companyâs Beyond platform is designed to give sponsors and CROs an effective, easy-to-operate to manage risks and visualize clinical trial data.

The companyâs Tempod 1000 USB device captures and stores clinical site temperature data automatically for simplified capture and reporting.